Organovo Holdings, Inc. is an early-stage medical laboratory and research company which designs and develops functional, three dimensional human tissue (also known as 3D bioprinting technology) for medical research and therapeutic applications. Organovo was established in 2007 and is headquartered in San Diego, California. The company uses its internally developed NovoGen MMX Bioprinter for 3D bioprinting.
Organovo Holdings, Inc. is an early-stage medical laboratory and research company which designs and develops functional, three dimensional human tissue...
cells can be arranged into complex structures, such as organs. Designed by Organovo, the NovoGen technology has been successfully integrated by Invetech with...
hearts. An early-stage medical laboratory and research company, called Organovo, designs and develops functional, three dimensional human tissue for medical...
years at UMC that he started his entrepreneurial activity, when he started Organovo in 2007, the first company in the space of bioprinting. In 2010 he returned...
scaffold first. In 2009, Organovo used this novel technology to create the first commercially available bioprinter. Soon after, Organovo's bioprinter was used...
clinical interventions in regenerative medicine. These companies include: Organovo, that does 3D tissue printing; Silverstone Solutions (acquired by BiologicTx...
Ctibiotech". Reuters. January 18, 2018. "A 3D Bioprinting Stock That's Not Organovo". Nanalyze. April 1, 2019. Beary, Brian (February 11, 2019). "ARAB HEALTH...
structures for study with the speed of magnetic printing. Bio-printing Organovo Souza GR, Molina JR, Raphael RM, Ozawa MG, Stark DJ, Levin CS, Bronk LF...
Global Information